Competitive Landscape by Indication
Data updated: Sep 20, 2026
158 indications, 118,652 trials mapped
Oncology
55,867 trialsSolid Tumor (Advanced)
9695 trials
895 Ph3
Merck, Sichuan Baili Pharmaceutical Co., Ltd., GSK
Breast Cancer
4015 trials
720 Ph3
AstraZeneca, Roche, Pfizer
Non-Hodgkin Lymphoma
3968 trials
358 Ph3
Roche, Merck, Genmab
NSCLC
3472 trials
565 Ph3
AstraZeneca, Merck, Sichuan Baili Pharmaceutical Co., Ltd.
Colorectal Cancer
2647 trials
373 Ph3
AbbVie, AstraZeneca, Revolution Medicines, Inc.
Prostate Cancer
2328 trials
357 Ph3
Novartis, AstraZeneca, Jiangsu HengRui Medicine Co., Ltd.
Multiple Myeloma
1958 trials
238 Ph3
Johnson & Johnson, GSK, AbbVie
AML
1842 trials
177 Ph3
AbbVie, Taiho Oncology, Inc., Kura Oncology, Inc.
Hematologic Malignancies
1737 trials
152 Ph3
Johnson & Johnson, Novartis, Merck
Melanoma
1676 trials
142 Ph3
Bristol-Myers Squibb, Merck, Regeneron
Pancreatic Cancer
1619 trials
141 Ph3
Revolution Medicines, Inc., Astellas, AstraZeneca
Hepatocellular Carcinoma
1442 trials
221 Ph3
AstraZeneca, Akeso, Roche
Ovarian Cancer
1413 trials
169 Ph3
AstraZeneca, AbbVie, Merck
Lung Cancer (General)
1331 trials
171 Ph3
Chongqing Precision Biotech Co., Ltd, AstraZeneca, Avistone Biotechnology Co., Ltd.
Head and Neck Cancer
1265 trials
116 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., AstraZeneca, Rakuten Medical, Inc.
MDS
1200 trials
99 Ph3
Bristol-Myers Squibb, Takeda, Taiho Oncology, Inc.
Gastric Cancer
1118 trials
186 Ph3
AstraZeneca, Astellas, Chongqing Precision Biotech Co., Ltd
Sarcoma
1061 trials
74 Ph3
USWM CT, LLC, Hansoh BioMedical R&D Company, Eli Lilly
Bladder Cancer
1003 trials
141 Ph3
Merck, AstraZeneca, Pfizer
Glioblastoma
988 trials
65 Ph3
Novartis, GT Medical Technologies, Inc., Philogen S.p.A.
ALL
947 trials
93 Ph3
Novartis, Amgen, Chongqing Precision Biotech Co., Ltd
Esophageal Cancer
818 trials
134 Ph3
AstraZeneca, Merck, Sichuan Baili Pharmaceutical Co., Ltd.
Brain Tumor
805 trials
57 Ph3
Pfizer, Nuvation Bio Inc., InSightec
Renal Cell Carcinoma
788 trials
72 Ph3
Merck, Exelixis, Bristol-Myers Squibb
CLL
785 trials
83 Ph3
BeOne Medicines, Acerta Pharma BV, AbbVie
Squamous Cell Carcinoma
664 trials
65 Ph3
Regeneron, Merck, AstraZeneca
Triple Negative Breast Cancer
611 trials
70 Ph3
Gilead, Novartis, AstraZeneca
Cholangiocarcinoma
606 trials
63 Ph3
AstraZeneca, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Eli Lilly
SCLC
571 trials
76 Ph3
Amgen, Boehringer Ingelheim, Merck
Cervical Cancer
535 trials
90 Ph3
AstraZeneca, Merck, Shanghai Bovax Biotechnology Co., Ltd.
Hodgkin Lymphoma
484 trials
36 Ph3
Merck, Takeda, Tessa Therapeutics
Endometrial Cancer
468 trials
48 Ph3
AstraZeneca, Merck, Genmab
CML
403 trials
44 Ph3
Novartis, Shenzhen TargetRx Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd.
Neuroendocrine Tumors
328 trials
42 Ph3
Advanced Accelerator Applications, Crinetics Pharmaceuticals Inc., Merck
Myelofibrosis
286 trials
35 Ph3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Novartis, Bristol-Myers Squibb
Mesothelioma
282 trials
18 Ph3
Novartis, AstraZeneca, Vivace Therapeutics, Inc
Thyroid Cancer
233 trials
35 Ph3
Exelixis, Eli Lilly, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
HER2+ Breast Cancer
193 trials
34 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., Roche, Jazz Pharmaceuticals
HER2- Breast Cancer
180 trials
20 Ph3
AstraZeneca, Novartis, BeOne Medicines
Merkel Cell Carcinoma
102 trials
6 Ph3
TuHURA Biosciences, Inc., ImmunityBio, Inc., Novartis
CNS
10,571 trialsMajor Depression
1790 trials
483 Ph3
Neurocrine Biosciences, Johnson & Johnson, Cybin IRL Limited
Alzheimer's Disease
1547 trials
296 Ph3
Eli Lilly, Bristol-Myers Squibb, Roche
Schizophrenia
955 trials
257 Ph3
Neurocrine Biosciences, Luye Pharma Group Ltd., Bristol-Myers Squibb
Parkinson's Disease
943 trials
176 Ph3
iRegene Therapeutics Co., Ltd., Roche, Luye Pharma Group Ltd.
Multiple Sclerosis
874 trials
236 Ph3
Roche, Novartis, Sanofi
Migraine
523 trials
199 Ph3
Pfizer, AbbVie, H. Lundbeck A/S
Epilepsy
470 trials
171 Ph3
Praxis Precision Medicines, Biohaven Therapeutics Ltd., Rapport Therapeutics Inc.
Anxiety
468 trials
109 Ph3
Otsuka Pharmaceutical Development & Commercialization, Inc., VistaGen Therapeutics, Inc., Beijing Union Pharmaceutical Factory Ltd
Alcohol Use Disorder
450 trials
72 Ph3
Eli Lilly, Pop Test Oncology LLC, Newleos Therapeutics, Inc.
Opioid Use Disorder
430 trials
91 Ph3
Go Medical Industries Pty Ltd, Akyso Therapeutics, LLC, Eli Lilly
ALS
353 trials
72 Ph3
Eli Lilly, Biogen, Amylyx Pharmaceuticals Inc.
ADHD
341 trials
122 Ph3
Otsuka Pharmaceutical Co., Ltd., Axsome Therapeutics, Inc., Bazelet Nehushtan LtD.
Autism Spectrum Disorder
340 trials
65 Ph3
Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Curemark
PTSD
321 trials
65 Ph3
Oui Therapeutics, Inc., COMPASS Pathways, Senseye, Inc.
Bipolar Disorder
292 trials
96 Ph3
Bristol-Myers Squibb, Intra-Cellular Therapies, Inc., Xenon Pharmaceuticals Inc.
Neuropathy
284 trials
70 Ph3
argenx, WinSanTor, Inc, Rinri Therapeutics
Huntington's Disease
106 trials
18 Ph3
Roche, Skyhawk Therapeutics, Inc., Novartis
OCD
84 trials
11 Ph3
Vericel Corporation, Biohaven Pharmaceuticals, Inc., Roche
Infectious Disease
10,068 trialsHIV
2302 trials
451 Ph3
ViiV Healthcare, Gilead, Merck
COVID-19
2262 trials
744 Ph3
BioNTech SE, ModernaTX, Inc., Pfizer
Influenza
1180 trials
332 Ph3
Valenta Pharm JSC, Changchun BCHT Biotechnology Co., GSK
Hepatitis C
1018 trials
295 Ph3
Atea Pharmaceuticals, Inc., Gilead, Merck
Hepatitis B
639 trials
112 Ph3
Ausper Biopharma Co., Ltd., GSK, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Malaria
608 trials
131 Ph3
GSK, Sanaria Inc., Novartis
Sepsis
491 trials
161 Ph3
ImmunityBio, Inc., AstraZeneca, Bayer
Tuberculosis
488 trials
119 Ph3
Shanghai Jiatan Pharmatech Co., Ltd, Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., GSK
RSV
295 trials
71 Ph3
GSK, Pfizer, Sanofi
Fungal Infections
225 trials
69 Ph3
Merck, F2G Biotech GmbH, Basilea Pharmaceutica
H. pylori
210 trials
49 Ph3
ARJ Medical, Inc., Catalysis SL, Xuanzhu Biopharmaceutical Co., Ltd.
C. difficile
176 trials
45 Ph3
AstraZeneca, Vedanta Biosciences, Inc., Acurx Pharmaceuticals Inc.
Bacterial Infections
174 trials
35 Ph3
Pfizer, Qpex Biopharma, Inc., CanSino Biologics Inc.
Metabolic
9,089 trialsType 2 Diabetes
2764 trials
846 Ph3
Eli Lilly, Novo Nordisk, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Obesity
1824 trials
416 Ph3
Novo Nordisk, Eli Lilly, Pfizer
Diabetes (General)
1629 trials
408 Ph3
Gan & Lee Pharmaceuticals., Novo Nordisk, Eli Lilly
Type 1 Diabetes
816 trials
180 Ph3
Eli Lilly, Sanofi, Novo Nordisk
Dyslipidemia
738 trials
282 Ph3
Addpharma Inc., Qilu Pharmaceutical Co., Ltd., Merck
NASH/NAFLD
687 trials
108 Ph3
GSK, Corcept Therapeutics, Madrigal Pharmaceuticals, Inc.
Diabetic Complications
631 trials
142 Ph3
Roche, AbbVie, Regeneron
Cardiovascular
7,095 trialsHypertension
2191 trials
645 Ph3
Merck, Boryung Pharmaceutical Co., Ltd, Addpharma Inc.
Heart Failure
1211 trials
286 Ph3
Novo Nordisk, HELP Therapeutics Co., Ltd., Tasly Pharmaceutical Group Co., Ltd
Stroke
1192 trials
405 Ph3
Beijing Suncadia Pharmaceuticals Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd, Clarion Cells, Inc.
Coronary Artery Disease
1083 trials
239 Ph3
Novartis, XyloCor Therapeutics, Inc., Beijing Inno Medicine Co., Ltd.
Atrial Fibrillation
502 trials
148 Ph3
Regeneron, Novartis, Anthos Therapeutics, Inc.
Myocardial Infarction
493 trials
141 Ph3
Novo Nordisk, Beijing Sungen Biomedical Technology Co., Ltd, Beijing Northland Biotech. Co., Ltd.
Thrombosis
281 trials
121 Ph3
Regeneron, Boston Scientific Corporation, Supergene, LLC
Arrhythmia
84 trials
28 Ph3
Cardurion Pharmaceuticals, Inc., Solid Biosciences Inc., Agiana Pharmaceuticals
Hypertrophic Cardiomyopathy
58 trials
19 Ph3
Cytokinetics, Shandong Suncadia Medicine Co., Ltd., Bristol-Myers Squibb
Immunology
5,830 trialsRheumatoid Arthritis
1098 trials
293 Ph3
AstraZeneca, Bristol-Myers Squibb, AbbVie
Psoriasis
1045 trials
335 Ph3
Johnson & Johnson, Bristol-Myers Squibb, Oruka Therapeutics, Inc.
Atopic Dermatitis
846 trials
217 Ph3
Pfizer, AbbVie, Keymed Biosciences Co.Ltd
Lupus
563 trials
83 Ph3
AstraZeneca, Novartis, Bristol-Myers Squibb
Ulcerative Colitis
548 trials
131 Ph3
Takeda, AbbVie, Roche
Crohn's Disease
541 trials
151 Ph3
Takeda, Johnson & Johnson, AbbVie
Psoriatic Arthritis
189 trials
82 Ph3
UCB Biopharma SRL, Bristol-Myers Squibb, AbbVie
Lupus Nephritis
151 trials
29 Ph3
Novartis, China Immunotech (Beijing) Biotechnology Co., Ltd., Roche
Myasthenia Gravis
142 trials
68 Ph3
argenx, UCB Biopharma SRL, AstraZeneca
Ankylosing Spondylitis
140 trials
45 Ph3
Bayer, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Jiangsu vcare pharmaceutical technology co., LTD
IgA Nephropathy
139 trials
42 Ph3
Novartis, Otsuka Pharmaceutical Development & Commercialization, Inc., Vera Therapeutics, Inc.
Hidradenitis Suppurativa
137 trials
32 Ph3
Incyte Corporation, Novartis, AbbVie
IBD
110 trials
25 Ph3
Disc Medicine, Inc, iCell Gene Therapeutics, Parvus Therapeutics, Inc.
Chronic Spontaneous Urticaria
107 trials
42 Ph3
Novartis, Celldex Therapeutics, Hangzhou Highlightll Pharmaceutical Co., Ltd
NMOSD
74 trials
23 Ph3
AstraZeneca, Amgen, Roche
Pain
4,583 trialsAcute Pain
2830 trials
776 Ph3
Eli Lilly, Grünenthal GmbH, AFT Pharmaceuticals, Ltd.
Postoperative Pain
1128 trials
238 Ph3
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., Shanghai Huilun Pharmaceutical Co., Ltd., Pacira Pharmaceuticals, Inc
Neuropathic Pain
325 trials
56 Ph3
Vertex Pharmaceuticals Incorporated, Eli Lilly, Haisco Pharmaceutical Group Co., Ltd.
Chronic Pain
300 trials
74 Ph3
Eli Lilly, Evon Medics LLC, iN Therapeutics Co., Ltd.
Respiratory
4,496 trialsAsthma
1445 trials
390 Ph3
GSK, AstraZeneca, Sanofi
COPD
1203 trials
356 Ph3
GSK, AstraZeneca, Haisco Pharmaceutical Group Co., Ltd.
Pneumonia
526 trials
185 Ph3
GSK, Qilu Pharmaceutical Co., Ltd., Biotest
Cystic Fibrosis
485 trials
132 Ph3
Vertex Pharmaceuticals Incorporated, Boehringer Ingelheim, Arcturus Therapeutics, Inc.
Allergic Rhinitis
373 trials
140 Ph3
Genrix (Shanghai) Biopharmaceutical Co., Ltd., Chengdu Kangnuoxing Biopharma,Inc., ALK-Abelló A/S
Idiopathic Pulmonary Fibrosis
312 trials
57 Ph3
Haisco Pharmaceutical Group Co., Ltd., Boehringer Ingelheim, Bristol-Myers Squibb
Chronic Rhinosinusitis with Nasal Polyps
152 trials
59 Ph3
Sanofi, GSK, Keymed Biosciences Co.Ltd
Musculoskeletal
1,775 trialsOsteoarthritis
1065 trials
285 Ph3
Eli Lilly, Pacira Pharmaceuticals, Inc, TBF Genie Tissulaire
Osteoporosis
379 trials
101 Ph3
Amgen, Shenzhen Salubris Pharmaceuticals Co., Ltd., Qilu Pharmaceutical Co., Ltd.
Gout
234 trials
52 Ph3
Crystalys Therapeutics, Jiangsu HengRui Medicine Co., Ltd., Atom Therapeutics Co., Ltd
Muscle Spasm
97 trials
46 Ph3
Chongqing Claruvis Pharmaceutical Co., Ltd., Ipsen, Merz Pharmaceuticals GmbH
Ophthalmology
1,582 trialsAge-Related Macular Degeneration
562 trials
136 Ph3
Roche, AbbVie, Adverum Biotechnologies, Inc.
Glaucoma
528 trials
148 Ph3
Glaukos Corporation, SpyGlass Pharma, Inc., AbbVie
Dry Eye
492 trials
138 Ph3
Bausch & Lomb Incorporated, Laboratorios Sophia S.A de C.V., Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Gastrointestinal
1,443 trialsNausea/Vomiting
399 trials
123 Ph3
Helsinn Healthcare SA, Fujian Shengdi Pharmaceutical Co., Ltd., Qilu Pharmaceutical (Hainan) Co., Ltd.
Peptic Ulcer
369 trials
98 Ph3
MediWound Ltd, TR Therapeutics, Applied Biologics, LLC
Constipation
296 trials
110 Ph3
Ardelyx, Bausch Health Americas, Inc., Shionogi
Diarrhea
229 trials
66 Ph3
Bausch Health Americas, Inc., Crinetics Pharmaceuticals Inc., Tasly Pharmaceutical Group Co., Ltd
GERD
150 trials
47 Ph3
Cinclus Pharma Holding AB, Onconic Therapeutics Inc., Phathom Pharmaceuticals, Inc.
Rare Disease
1,415 trialsImmune Thrombocytopenia
375 trials
111 Ph3
Novartis, argenx, Amgen
Sickle Cell Disease
373 trials
71 Ph3
Novartis, Agios Pharmaceuticals, Inc., Forma Therapeutics, Inc.
Hemophilia
292 trials
129 Ph3
Pfizer, Roche, Suzhou Alphamab Co., Ltd.
Duchenne Muscular Dystrophy
167 trials
36 Ph3
Sarepta Therapeutics, Inc., NS Pharma, Inc., Italfarmaco
Fabry Disease
62 trials
29 Ph3
Amicus Therapeutics, Chiesi Farmaceutici S.p.A., Idorsia Pharmaceuticals Ltd.
Spinal Muscular Atrophy
61 trials
22 Ph3
GeneCradle Inc, Biogen, Roche
Gaucher Disease
52 trials
18 Ph3
Spur Therapeutics, Prevail Therapeutics, Genzyme, a Sanofi Company
Mastocytosis
28 trials
5 Ph3
Blueprint Medicines Corporation, Cogent Biosciences, Inc., MacroGenics
CDKL5 Deficiency Disorder
5 trials
3 Ph3
Zogenix, Inc., Immedica Pharma AB, Marinus Pharmaceuticals
Women's Health
1,105 trialsInfertility
494 trials
171 Ph3
Qilu Pharmaceutical Co., Ltd., Fertility Center of Las Vegas, Prokrea BCN, S.L.
PCOS
209 trials
61 Ph3
Wellizen Australia, Fujian Shengdi Pharmaceutical Co., Ltd., Dexa Medica Group
Menopause
186 trials
50 Ph3
Bayer, Astellas, AbCellera Biologics Inc.
Endometriosis
168 trials
44 Ph3
AbbVie, Kissei Pharmaceutical Co., Ltd., Hope Medicine (Nanjing) Co., Ltd
Contraception
48 trials
13 Ph3
YourChoice Therapeutics, Inc., Mylan Pharmaceuticals Inc, Next Life Sciences
Renal
1,085 trialsDermatology
950 trialsAcne
386 trials
112 Ph3
Sanofi, Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd., Galderma R&D
Alopecia
261 trials
66 Ph3
Pfizer, Applied Biology, Inc., Veradermics, Inc.
Rosacea
126 trials
39 Ph3
Tarsus Pharmaceuticals, Inc., Novartis, Galderma R&D
Vitiligo
118 trials
33 Ph3
Incyte Corporation, Pfizer, Jiangsu HengRui Medicine Co., Ltd.
Skin Infections
59 trials
17 Ph3
GSK, Melinta Therapeutics, Inc., Durata Therapeutics Inc., an affiliate of Allergan plc
Urology
656 trialsHepatology
442 trialsSleep
348 trialsEndocrine
252 trialsGrowth Hormone Deficiency
97 trials
35 Ph3
Changchun GeneScience Pharmaceutical Co., Ltd., Lumos Pharma, Xiamen Amoytop Biotech Co., Ltd.
Acromegaly
53 trials
18 Ph3
Marea Therapeutics, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Debiopharm International SA
Hypothyroidism
44 trials
11 Ph3
Neuvosyn Laboratories, LLC, AbbVie, IBSA Institut Biochimique SA
Adrenal Insufficiency
31 trials
6 Ph3
Neurocrine UK Limited
Hyperthyroidism
27 trials
8 Ph3
Biohaven Therapeutics Ltd., argenx, Merida Biosciences
Click any indication to see full competitive landscape (all sponsors, trials, phases).
Data: ClinicalTrials.gov | Mapping: Indication Taxonomy